Martin Slade, MPH, PhD
Lecturer in Occupational MedicineDownloadHi-Res Photo
Cards
Appointments
Contact Info
About
Titles
Lecturer in Occupational Medicine
Biography
Mr. Slade's work focuses on the development of analytical models to evaluate the effects of physical, social and environmental factors on the patterns of disease and injury within the workplace setting, including non-traditional settings such as the military and merchant mariners. In recent years, he has been the lead statistician for four clinical trials conducted by the Department of Defense to determine the effect of pharmacological agents on prevention of hearing loss as well as mild traumatic brain injuries.
Appointments
Occupational & Environmental Medicine Program
LecturerPrimaryEnvironmental Health Sciences
LecturerSecondary
Other Departments & Organizations
- Center for Medical Education Faculty Associates
- Environmental Health Sciences
- General Internal Medicine
- Internal Medicine
- Occupational & Environmental Medicine Program
- Yale School of Public Health
Education & Training
- PhD
- Walden University, Public Health (2021)
- MPH
- Yale University School of Medicine (2001)
- BS
- Syracuse University (1980)
- Postgraduate Trainee
- Harvard School of Public Health
Research
Overview
Mr. Slade's current research interests include the development of analytical models to evaluate the effects of physical and psychosocial factors on the patterns of disease and injury within industrial workplaces as well as psychosocial influences on aging, in particular, how older individuals’ perceptions of aging affect cognition and health in old age. Additionally, Mr. Slade's research interests include the effect of mechanical hearing protection and pharmacological interventions on the reduction of noise induced hearing loss.
Public Health Interests
Aging; Occupational Health
ORCID
0000-0001-7480-7470
Research at a Glance
Yale Co-Authors
Frequent collaborators of Martin Slade's published research.
Publications Timeline
A big-picture view of Martin Slade's research output by year.
Becca Levy, PhD
Carrie A Redlich, MD, MPH, BA
Cassius Iyad Ochoa Chaar, MD, MPH, MS, RPVI
Raul J Guzman, MD
Carine Sakr, MD, MPH
Edouard Aboian, MD
55Publications
805Citations
Publications
2024
Variations in Antithrombotic Combinations and Prescription Durations After Lower Extremity Revascularization in Patients With Peripheral Arterial Disease
Wells N, Alameddine D, Dhanda U, Tran L, Silva D, Slade M, Guzman R, Chaar C. Variations in Antithrombotic Combinations and Prescription Durations After Lower Extremity Revascularization in Patients With Peripheral Arterial Disease. Journal Of Vascular Surgery 2024, 80: e135-e136. DOI: 10.1016/j.jvs.2024.07.076.Peer-Reviewed Original ResearchComparative Outcomes of Peripheral Vascular Intervention in Patients Discharged on Clopidogrel in Combination With Factor Xa Inhibitors or Aspirin
Huttler J, Rodriguez P, Dandu C, Piazza G, Kabbani L, Kashyap V, Slade M, Zwibelman H, Guzman R, Chaar C. Comparative Outcomes of Peripheral Vascular Intervention in Patients Discharged on Clopidogrel in Combination With Factor Xa Inhibitors or Aspirin. Journal Of Vascular Surgery 2024, 79: e290-e292. DOI: 10.1016/j.jvs.2024.03.375.Peer-Reviewed Original ResearchThe Incidence and Significance of Bleeding in Patients With Advanced Peripheral Arterial Disease
Hundito A, Wells N, Tuttle M, Alameddine D, Huttler J, Slade M, Strosberg D, Lee A, Guzman R, Chaar C. The Incidence and Significance of Bleeding in Patients With Advanced Peripheral Arterial Disease. Journal Of Vascular Surgery 2024, 79: e60-e61. DOI: 10.1016/j.jvs.2024.03.051.Peer-Reviewed Original ResearchClinical Implications of Low Body Mass Index on Endovascular Lower Extremity Revascularization
Pinto Rodriguez P, Alameddine D, Huttler J, Damara F, Slade M, Cardella J, Guzman R, Chaar C. Clinical Implications of Low Body Mass Index on Endovascular Lower Extremity Revascularization. Annals Of Vascular Surgery 2024, 106: 350-359. PMID: 38810726, DOI: 10.1016/j.avsg.2024.02.031.Peer-Reviewed Original ResearchConceptsPeripheral vascular interventionsPeripheral arterial diseaseLower body mass indexUnderweight patientsLong-term outcomesBody mass indexNonobese patientsMass indexRetrospective analysis of patientsRate of thrombotic complicationsHigher 30-day mortalityRates of amputation-free survivalRate of reinterventionOutcomes of patientsPeripheral arterial disease patientsAnalysis of patientsKaplan-Meier analysisImpact of malnutritionBaseline demographic characteristicsChronic limb-threatening ischemiaEpidemic of obesityOptimization of nutritionLonger hospital lengthAdverse limb eventsAmputation-free survivalComparative Outcomes of Peripheral Vascular Interventions in Patients on Chronic Anticoagulation with Factor Xa Inhibitors and Vitamin K Antagonists
Huttler J, Alameddine D, Damara F, Rodriguez P, Wu Z, Slade M, Strosberg D, Ochoa Chaar C. Comparative Outcomes of Peripheral Vascular Interventions in Patients on Chronic Anticoagulation with Factor Xa Inhibitors and Vitamin K Antagonists. Annals Of Vascular Surgery 2024, 104: 185-195. PMID: 38493886, DOI: 10.1016/j.avsg.2023.12.092.Peer-Reviewed Original ResearchConceptsVitamin K antagonistsPeripheral arterial diseaseChronic anticoagulationLong-term outcomesFactor Xa inhibitorsAmputation-free survivalK antagonistsXa inhibitorsVitamin K antagonist groupMultivariate logistic regression analysisOutcomes of patientsKaplan-Meier analysisCox proportional hazards regressionLong-term followRate of hematomaProportional hazards regressionPeripheral vascular interventionsLogistic regression analysisOptimal regimenPatient demographicsAnticoagulation regimensVenous thromboembolismAtrial fibrillationFXaIProcedural characteristicsThe Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions
Alameddine D, Damara F, Pinto Rodriguez P, Huttler J, Slade M, Arhuidese I, Aboian E, Ochoa Chaar C. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions. Annals Of Vascular Surgery 2024, 103: 47-57. PMID: 38387798, DOI: 10.1016/j.avsg.2023.12.071.Peer-Reviewed Original ResearchConceptsImpact of cilostazolPeripheral vascular interventionsPeripheral arterial diseaseTreatment of intermittent claudicationRates of long-term mortalityPeripheral vascular interventional proceduresKaplan-Meier methodCongestive heart failureLong-term mortalityLong-term outcomesEndovascular peripheral interventionsRenal complicationsPatient demographicsBaseline characteristicsHeart failureDiabetes mellitusArtery diseaseIntermittent claudicationCilostazolPatientsVascular interventionsPeripheral interventionsClaudicationOutcomesInterventionImpact of Structured Reporting For Lung Cancer Screening Low-Dose CT Scan Incidental Findings on Physician Management
Kunitomo Y, Sather P, Killam J, Pisani M, Slade M, Tanoue L. Impact of Structured Reporting For Lung Cancer Screening Low-Dose CT Scan Incidental Findings on Physician Management. CHEST Journal 2024, 166: 896-898. PMID: 38346557, DOI: 10.1016/j.chest.2024.02.002.Peer-Reviewed Original ResearchAltmetricInsulin Requirement and Infrainguinal Bypass Outcomes in Patients with Peripheral Arterial Disease
Alameddine D, Satam K, Slade M, Wang H, Mena-Hurtado C, Turner J, Inzucchi S, Ochoa Chaar C. Insulin Requirement and Infrainguinal Bypass Outcomes in Patients with Peripheral Arterial Disease. Annals Of Vascular Surgery 2024, 102: 25-34. PMID: 38307234, DOI: 10.1016/j.avsg.2023.11.044.Peer-Reviewed Original ResearchConceptsInsulin-requiring diabetes mellitusPeripheral arterial diseaseDiabetes mellitusInfrainguinal bypassInsulin requirementsArtery diseaseRisk of MALEBypass surgeryImpact of insulin useRates of primary patencyVascular Quality Initiative databaseOutcomes of patientsPeripheral arterial bypass surgeryInfrainguinal bypass surgeryStratification of patientsCrude rateElevated hemoglobin A1cArtery bypass surgeryAssociation of DMChronic limb-threatening ischemiaIncreased risk of MALEVascular Quality InitiativeLower extremity revascularizationAdverse limb eventsLimb-threatening ischemia
2023
Development of an innovative curriculum for paediatricians on peanut allergy prevention: How do we address current guidelines?
Leeds S, Slade M, Hafler J, Samady W, Jiang J, Bilaver L, Gupta R. Development of an innovative curriculum for paediatricians on peanut allergy prevention: How do we address current guidelines? The Clinical Teacher 2023, 21: e13689. PMID: 37935587, DOI: 10.1111/tct.13689.Peer-Reviewed Original ResearchAltmetricConceptsPeanut allergy preventionAllergy preventionNeeds assessmentBroad clinical practiceSpecialty-specific guidelinesBaseline knowledge scoresPrimary preventionProspective studyPeanut allergyClinical guidelinesRisk infantsCurrent guidelinesClinical practiceKnowledge scoreClinical casesPediatriciansMajority of respondentsPreventionVariable evidenceEarly introductionKnowledge surveyAllergyKnowledge questionsInteractive curriculumGuidelinesArterial dissection during peripheral vascular interventions
Damara F, Alameddine D, Slade M, Cardella J, Tonnessen B, Guzman R, Ochoa Chaar C. Arterial dissection during peripheral vascular interventions. Journal Of Vascular Surgery 2023, 79: 339-347.e6. PMID: 37838217, DOI: 10.1016/j.jvs.2023.10.004.Peer-Reviewed Original ResearchCitationsAltmetricConceptsPeripheral vascular interventionsReintervention-free survivalPeripheral arterial diseasePrimary patencyArterial dissectionLower primary patencyArterial diseaseVascular interventionsVascular Quality Initiative databaseLonger occlusion lengthAmputation-free survivalOutcomes of patientsHistory of smokingKaplan-Meier curvesProportional hazards regressionTrend of incidencePrimary endpointFemoropopliteal diseaseLimb outcomesEndovascular therapyFemoropopliteal segmentHazards regressionOpen surgeryOcclusion lengthTreatment modalities
News
News
- May 05, 2023
Becca Levy and the Fight Against Ageism
- April 13, 2023Source: Medium
Positive Views on Aging Can Sharpen Your Mind and Boost Health and Happiness
- April 13, 2023
People who think positively about aging are more likely to recover memory
- November 12, 2018
Health costs of ageism calculated at $63 billion annually, study finds
Get In Touch
Contacts
Academic Office Number